๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

L-asparaginase activity in plasma and other biological fluids

โœ Scribed by Morton K. Schwartz; Edward D. Lash; Herbert F. Oettgen; Frank A. Tomao


Publisher
John Wiley and Sons
Year
1970
Tongue
English
Weight
962 KB
Volume
25
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


An automated method has been developed for the assay of L-asparaginase activity in plasma and other biological fluids. By means of this method, C asparaginase activity has been determined in plasma, cerebrospinal fluid, and urine in patients receiving E. coli L-asparaginase (EC-2) therapy. T h e height of the plasma activity was related to the dosage. In some patients, the plasma enzyme activity fell despite continued administration of L-asparaginase. The disappearance of the E. coli L-asparaginase from the plasma was related to the commercial source of the enzyme. From one source the half-life in adults was 11.2 k 2.7 hours and from another, 22.6 2 4.7 hours. Intramuscular administration of enzyme resulted in plasma levels that were about half those observed following intravenous administration of enzyme. Following intravenous administration of L-asparaginase at doses up to 5000 IU/kg/day, no activity was found in urine. At the highest dosage levels, small amounts of activity were observed in cerebrospinal fluid. When enzyme was injected directly into the cerebrospinal fluid, there was a rapid transfer of enzyme to the plasma, and the activity in the spinal fluid was reduced to negligible amounts within 24 hours.

-ASPARAGINASE (L-ASPARAGINE AMINOHYDRO-L lase EC 3.5.1.1), the enzyme which catalyzes the hydrolysis of asparagine to form aspartic acid and ammonia, is present in many animal tissues, bacteria, and plank20 It is found in the serum of guinea pigs and other rodents, but not in that of man.13 One of the isozymes of L-asparaginase (EC-2) purified from Escherichia coli, the enzyme from guinea pig serum and, to a lesser extent, that purified from chicken liver cause the regression of certain lymphomatous tumors of mice, rats, and dogs.3, 4. 17

Clinical trials with purified E . coli asparaginase (EC-2) have indicated a sensitivity of lymphoblastic leukemia in man to this


๐Ÿ“œ SIMILAR VOLUMES


Studies on neutralization of L-asparagin
โœ Srikrishna Vadlamudi; Martin Padarathsingh; Enzo Bonmassar; Vaman Waravdekar; Ab ๐Ÿ“‚ Article ๐Ÿ“… 1971 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 545 KB

L-asparaginase was effective in increasing the life span of leukemic (L5178Y) mice. However, the therapeutic effect of the drug was reduced when this treatment was preceded by a series of pretreatments (relative to tumor implantation) with the drug. T h e data from in vitro and in vivo studies revea

Determination of the concentration and s
โœ Victor C. Gavino; Bernard Vinet; France David; Michel Garneau; Henri Brunengrabe ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 480 KB

The concentration of acetone dissolved in liver perfusion medium was determined by injection of the sample into a gas chromatograph equipped with a Carbopack/Carbowax-packed glass column. Interference from labile acetoacetate which readily decomposes to acetone was eliminated by treating the samples

The effect of L-asparaginase on plasma c
โœ Norma K. C. Ramsay; Peter F. Coccia; William Krivit; Mark E. Nesbit; J. Roger Ed ๐Ÿ“‚ Article ๐Ÿ“… 1977 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 328 KB ๐Ÿ‘ 2 views

Serial coagulation studies were performed in 26 pediatric patients with acute lymphoblastic leukemia during initial induction therapy with vincristine, prednisone, and L-asparaginase. Prolongation of screening coagulation tests was frequent: prothrombin time (in 16 of 26 patients), partial thrombopl

GLC determination of bretylium in biolog
โœ Chii-Ming Lai; Burde L. Kamath; James E. Carter; Paul Erhardt; Zee M. Look; Avra ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 338 KB ๐Ÿ‘ 1 views